Deciphera Pharmaceuticals Secures $75,000,000 Series B Financing

  • Feed Type
  • Date
  • Company Name
    Deciphera Pharmaceuticals
  • Mailing Address
    1601 Trapelo Road Waltham, MA 02451 USA
  • Company Description
    Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds will enable Deciphera to advance its pipeline of proprietary switch control kinase inhibitors through multiple key clinical milestones.
  • M&A Terms
  • Venture Investor
    New Leaf Venture Partners
  • Venture Investor

Trending on Xconomy